mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.001 |
1 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00071 |
1 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.0007 |
1 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.00077 |
1 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.00075 |
1 |